Goodwin Procter LLP advised Centerview Partners on the deal. Centerview Partners acted as financial advisor to Immunomedics, Inc. (NASDAQ: IMMU), on the definitive agreement pursuant to…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
